SEATTLE--(BUSINESS WIRE)--Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the Mantarray™ platform for human-relevant 3D engineered muscle tissue ...
Curi Bio’s “Mantarray” platform enables muscle cells to be grown in three dimensions. Muscle tissue, in pink, is growing in each circular well. (Curi Bio Photo) Seattle-based startup Curi Bio has ...
An icon in the shape of a calendar. A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". The word "Markets Insider". SEATTLE, ...
SEATTLE & COLUMBUS, Ohio, March 20, 2026--(BUSINESS WIRE)--Curi Bio, a world leader in human-relevant 3D tissue technology, and Battelle, the world's largest independent nonprofit research and ...
Curi Bio unlocks novel workflows and delivers functional human data to inform biopharmaceutical R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, ...
Accelerating Drug Discovery with Human-Relevant 3D Engineered Muscle Tissue Analysis SEATTLE--(BUSINESS WIRE)--Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, ...
Curi Bio, a world leader in human-relevant 3D tissue technology, and Battelle, the world’s largest independent nonprofit research and development organization, today announced a strategic partnership ...
Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the Mantarray™ platform for human-relevant 3D engineered muscle tissue (EMT) analysis. Curi’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results